SMTL ID : 7ukv.1

Wild type EGFR in complex with Lazertinib (YH25448)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x ZRT: N-[5-{[(4P)-4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl]amino}-4-methoxy-2-(morpholin-4-yl)phenyl]propanamide(Covalent)

ZRT.1: 17 residues within 4Å: Chain A: L.24, A.49, K.51, E.68, T.96, Q.97, L.98, M.99, P.100, G.102, C.103, D.106, R.147, N.148, L.150, T.160, D.161 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:A.49, A:L.150 Hydrogen bonds: A:M.99, A:M.99, A:C.103, A:D.106, A:D.106 Water bridges: A:T.160 Salt bridges: A:D.161

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Heppner, D.E. et al., Structural Basis for Inhibition of Mutant EGFR with Lazertinib (YH25448). Acs Med.Chem.Lett. (2022)

Release Date

2022-11-23

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor